// App-Quantinova.ai

: Convergence of clinical and computational phenotypes for rare variant association study (RVAS) in pulmonary arterial hypertension

Researchers

Presenter

  • Emilia Swietlik

Principal Investigators

  • Daniel Greene

  • Kathryn Auckland

  • Tobias Tilly

  • Jennifer Martin

  • Nicholas Morrell

  • Stefan Gräf

Medical Centers

  • University of Cambridge, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • Rho Guanine Nucleotide Exchange Factor 16

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved